Uric acid is associated with cardiovascular disease (CVD) and its risk factors. Here, we examined the association between the serum uric acid level and incident metabolic syndrome in a Japanese general population. This retrospective, observational study was based on data obtained from an annual health checkup program in Gunma Prefecture, Japan. We evaluated 14,793 participants who did not use antihypertensive or antidiabetic medications and did not present with CVD or metabolic syndrome at the study baseline in 2009. Metabolic syndrome was defined as per the Japanese diagnostic criteria. A discrete proportional hazards regression model was used to evaluate the association between the serum uric acid level at baseline and the incident metabolic syndrome through 2012 and was adjusted for age, gender, waist circumference, systolic and diastolic blood pressure, fasting blood glucose, high-density lipoprotein cholesterol, and triglyceride. At baseline, the average age of the participants was 48.9 years, who were comprised of 40% women. The mean serum uric acid level at baseline was 5.3 ± 1.4 mg/dL. During the three-year follow-up, 7% of the cohort (n = 1,031) developed metabolic syndrome. The uric acid level was strongly associated with incident metabolic syndrome in the multivariable model (adjusted hazard ratio: 1.10; 95% confidence interval, 1.04-1.17; P < 0.01 per 1 mg/dL increase for uric acid). Higher uric acid levels were independently associated with a greater risk of incident metabolic syndrome in a Japanese general population.
U ric acid is synthesized by the liver during purine metabolism, and serum uric acid levels are determined by the balance between uric acid production and excretion. It has been reported that the uric acid level is associated with incident cardiovascular disease (CVD) and its risk factors, [1] [2] [3] [4] [5] which include high blood pressure, diabetes, dyslipidemia, smoking, and obesity. Although these risk factors alone can cause CVD, it has been suggested that the risk of CVD development increases if factors overlap, even if each factor is low.
Various diagnostic criteria for metabolic syndrome, which is a combination of visceral fat obesity with hypertension, hyperglycemia, and lipid metabolism abnormality, [6] [7] [8] [9] [10] [11] have been proposed internationally. It has been reported that metabolic syndrome is closely associated with incident CVD. [12] [13] [14] [15] [16] [17] Although both uric acid levels and metabolic syndrome are associated with CVD, only a small number of studies have evaluated the association between uric acid levels and metabolic syndrome. In the present study, the relationship between uric acid levels and incident metabolic syndrome in a Japanese general population was examined using a discrete proportional hazards regression model.
Methods
Subjects: This retrospective, observational study is based on data obtained from an annual health checkup program at Gunma Chuo Hospital, Japan. The participants' enrolment for the present study is presented in the Figure. The data of 24,112 participants who participated in the health checkup program at baseline in 2009 were used. During the three-year follow-up, 17,254 participants returned for at least one follow-up visit in 2011 or 2012. The final cohort comprised 14,793 participants (8,862 men and 5,931 women), the inclusion criteria being no metabolic syndrome at baseline, no use of antihypertensive or antidiabetic drugs, and no CVD history.
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Figure.
Participants' enrolment in the present study.
ber: 2014-004, 2015-009) and Gunma University Hospital (approval number: 26-47), with a waiver of informed consent. All procedures were in accordance with the Declaration of Helsinki. Measurements: Data regarding the age, gender, height, weight, body mass index (BMI), waist circumference, systolic blood pressure, diastolic blood pressure, fasting triglyceride, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein cholesterol, fasting glucose, serum creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and serum uric acid values were recorded annually. The estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease study equation modified for the Japanese population: 194 × serum creatinine −1.094 × age −0.287 × 0.739 (if women). In order to collect data related to medical complications, information concerning the use of medications (antihypertensive drugs, antidiabetic drugs, and antihyperlipidemic drugs) and the patient's CVD history was obtained. Averaged values for systolic and diastolic blood pressure were calculated, and each value was measured twice in a sitting position. Criteria for metabolic syndrome: Metabolic syndrome as defined by the diagnostic criteria in Japan 9) is a waist circumference of ! 85 cm in men and ! 90 cm in women, which is equivalent to a visceral fat area of ! 100 cm 2 , in addition to two of the following conditions: dyslipidemia (triglycerides !150 mg/dL or HDL cholesterol < 40 mg/ dL), high blood pressure (systolic blood pressure !130 mmHg or diastolic blood pressure !85 mmHg), or hyperglycemia (fasting glucose !110 mg/dL). In the present study, a case that met the above metabolic syndrome diagnostic criteria at follow-up visits was defined as a newincidence metabolic syndrome. Statistical analysis: Continuous variables were represented as the mean ± standard deviation (SD) unless otherwise specified, and categorical variables were represented as percentages. A comparison of continuous variables of the participants' backgrounds between two groups with or without incident metabolic syndrome was performed using Student's t-test for parametric parameters and Mann-Whitney U test for nonparametric parameters. A comparison of those between three or more groups was performed using one-way analysis of variance for parametric parameters and Kruskal-Wallis test for nonparametric parameters. The χ 2 test was used for categorical variables.
We utilized discrete proportional hazards (complementary log-log) regression models to estimate the hazard ratios (HRs) for baseline uric acid levels with incident metabolic syndrome. This model is suitable for data analysis in which many events are observed discretely, as what occurred in the annual checkup data of this study. Stratification of gender-specific baseline uric acid levels was performed by quartile, and HRs were compared. Similarly, the HRs were also calculated using the uric acid value as a continuous value. Model 1 was adjusted for age and gender, and Model 2 was adjusted for the covariates in Model 1 plus the diagnostic criteria of metabolic syndrome, such as waist circumference, blood pressure, fasting glucose, HDL cholesterol, and triglycerides. Further adjustment for renal and liver markers, including eGFR, AST, and ALT individually and all together, was performed. Furthermore, the relationship between uric acid and gender in incident metabolic syndrome was examined in a model containing uric acid and gender interaction SUMIYOSHI, ET AL 164 (9) 165 (8) 164 (9) 165 (9) 164 (9) 0.18 Weight (kg)
62 (11) 59 (10) 60 (10) 62 (11) 64 (12 82 (8) 80 (7) 82 (7) 83 (8) 85 (8) < 0.001 Women WC (cm) 77 (9) 75 (8) 76 (8) 78 (8) 81 (9) < 0.001 Fasting glucose (mg/dL) 93 (16) 94 (23) 92 (15) 93 (11) 93 (10) < 0.001 HDL (mg/dL) 66 (17) 67 (16) 67 (17) 65 (17) 64 ( 124 (16) 122 (16) 123 (16) 125 (15) 127 (16) < 0.001 DBP (mmHg)
78 (11) 76 (11) 77 (10) 79 (11) 81 (11 21 (9) 19 (7) 20 (8) 21 (9) 23 (13) < 0.001 ALT (U/L)
22 (16) 19 (12) 20 (13) 22 (16) 26 (21) terms. All statistical analyses were carried out using Stata 14.0 (StataCorp, College Station, TX, USA) with twosided P-values < 0.05 considered significant.
Results
Baseline characteristics:
The participants' characteristics stratified by gender-specific uric acid quartile at baseline are presented in Table I . The mean age was 48.9 ± 9.6 years, and the proportion of women was 40%. The baseline average serum uric acid level was 5.3 ± 1.4 mg/dL (men: 5.9 ± 1.2 mg/dL; women: 4.3 ± 1.0 mg/dL). Participants with higher uric acid levels had a higher BMI, waist circumference, triglyceride level, and average blood pressure, but a lower HDL cholesterol level. During the three-year follow-up, 1,031 (7%) participants newly developed metabolic syndrome. The average observation period was 2.86 ± 0.39 years. In this new-incidence metabolic syndrome group, cardiovascular risks such as obesity, elevated blood pressure, and hyperglycemia and the uric acid level were higher than those in the non-new-incidence group at baseline (Table II) . Relationship between uric acid levels and incident metabolic syndrome: An examination of the interaction terms related to the gender of subjects with uric acid and incident metabolic syndrome revealed a significant difference (P < 0.01) in both univariate and multivariate models, prompting a gender-specific analysis. In the univariate model, the HRs were 1.26 (95% CI: 1.20-1.34; P < 0.01 per 1 mg/dL increase for uric acid) in men and 2.07 (95% CI: 1.79-2.41; P < 0.01 per 1 mg/dL increase for uric acid) in women. In the multivariate model adjusted for age, waist circumference, blood pressure, fasting glucose, HDL cholesterol, and triglycerides, the HRs were 1.08 (95% CI: 1.02-1.15; P < 0.05) in men and 1.31 (95% CI: 1.06-1.61; P < 0.05) in women.
Discussion
In the present study, we examined the relationship between baseline serum uric acid levels and new-incident metabolic syndrome at follow-up using health checkup data. The serum uric acid level in the study population was a predictor of metabolic syndrome independent of other factors in both men and women.
Metabolic syndrome refers to a condition in which two or more of hyperglycemia, hypertension, and dyslipidemia are present in visceral fat obesity; it has previously been referred to as syndrome X, multiple-risk-factor syndrome, and visceral fat syndrome. Metabolic syndrome is an integrated disease concept. [6] [7] [8] [9] [10] [11] It has been reported in previous cross-sectional studies that the prevalence of ASSOCIATION OF URIC ACID WITH METABOLIC SYNDROME Values are represented as the mean (SD), *median (25th-75th percentile range), or %. MetS indicates metabolic syndrome. Other abbreviations are as in Table I . metabolic syndrome increases as the serum uric acid level increases.
18) The present study revealed that the baseline uric acid level is associated with future incident metabolic syndrome. Regarding the mechanism of metabolic syndrome, Furukawa et al. 19) proposed the induction of both inflammation and oxidative stress in adipocytes by uric acid; an increase in oxidative stress in adipocytes causes insulin resistance by an abnormal increase in the secretion of inflammatory adipocytokines and a decrease in adiponectin, leading to incident metabolic syndrome. Urate transporter 1 is expressed in adipocytes, and uric acid absorbed directly by adipocytes increases the level of activated oxygen via the activation of NADPH oxidase in adipocytes, resulting in the induction of both inflammation and oxidative stress. 20) Additionally, Baldwin et al. 21) demonstrated that the administration of the Allium uric-acidlowering agent allopurinol to metabolic syndrome model mice with mutated leptin receptors reduces adipocytokine secretion and insulin resistance. Thus, both inflammation and oxidative stress, induced by uric acid in adipocytes, cause abnormal adipocytokine secretion, leading to insulin resistance and metabolic syndrome development. Several prior studies investigating the relationship between uric acid and incident metabolic syndrome have been conducted. Ishizaka et al. 22 ) studied 8,144 subjects over nine years with a BMI of !25 kg/m 2 as the cut-off value instead of the metabolic syndrome diagnostic criterion of abdominal circumference as per the National Cholesterol Education Program (NCEP).
7) The odds ratio for the lowest quartile of the highest uric acid value quartile SUMIYOSHI, ET AL group at baseline was 2.27 (95% CI: 1.90-2.72; P < 0.0001) in the model adjusted for age, gender, total cholesterol value, and smoking. In Oda's study, 23) 1,606 men and 953 women were targeted over three years. Instead of the waist circumference of the NCEP diagnostic criteria, 7) cut-off values of !90 cm for men and !80 cm for women, which are the recommended values according to the Japanese International Diabetes Federation (IDF), 8) were used. The HRs per 1 SD increase in baseline uric acid adjusted by metabolic syndrome components and age, smoking, drinking, physical activity, antihypertensive drugs, antidiabetic drugs, lipid-lowering drugs, CVD, and stroke were 1.282 (95% CI: 1.097-1.499; P = 0.002) in men and 1.354 (95% CI: 1.041-1.762; P = 0.024) in women. In addition, in the same multivariate model, HRs for the lowest quartile of the highest uric acid value quartile were 2.206 (95% CI: 1.344-3.620; P = 0.002) in men and 3.110 (95% CI: 1.121-8.627; P = 0.029) in women. The baseline uric acid level was an independent predictor of incident metabolic syndrome, although no significant differences were found in HRs per uric acid level per 1 mg/dL increase. The results of the above two studies and our present study are consistent, suggesting that uric acid is an independent predictor of incident metabolic syndrome. The differences in HRs in our study compared with the previous studies are probably related to the differences in the patients' backgrounds at baseline. In our study, we focused on healthy subjects who did not use antihypertensive drugs and antidiabetic medications at baseline and who had no CVD history. Furthermore, because in our study we analyzed all the components of metabolic syndrome as an adjustment factor in the multivariate analysis, we strongly support the independent association of uric acid with incident metabolic syndrome.
Gender analysis of HRs per 1 mg/dL increase in uric acid revealed that HRs in women were higher than those in men. This appears to be because the uric acid level in women was lower than that in men at baseline, so the HR per 1 mg/dL increase caused a larger effect. Hakoda et al. 24) reported that a higher risk of death in women with CVD is associated with an increased uric acid level compared with men, although the uric acid level in women is lower than that in men, and the results of our study also support these findings.
Because we targeted a Japanese population in the present study, we applied the Japanese diagnostic criteria of metabolic syndrome. The latest international diagnostic criteria for metabolic syndrome were announced jointly by the IDF; the National Heart, Lung, and Blood Institute; the American Heart Association; the World Heart Federation; the International Atherosclerosis Society; and the International Association for the Study of Obesity in 2009. These diagnostic criteria differ from the Japanese diagnostic criteria in that the waist circumference criterion was established for each race (!90 cm and !80 cm in Japanese men and women, respectively), and waist circumference is not an essential criterion. A comparison with international criteria is necessary to determine whether the difference in the diagnostic criteria, particularly the waist circumference criterion, influences the HR.
A limitation of the present study was that the data did not contain information pertaining to the use of uricacid-lowering drugs. Therefore, the effect of uric-acidlowering drugs on the association of uric acid with metabolic syndrome could not be evaluated in the present study. Information regarding the use of other drugs that affect uric acid levels, such as loop diuretics and thiazide diuretics, was also lacking. Moreover, the serum uric acid level was a single measurement value, and the influence of previous drinking and meals was not considered. Furthermore, because we analyzed only healthy subjects who did not use antihypertensive drugs or antidiabetic medications, we could not investigate the relationship between uric acid levels and incident metabolic syndrome in patients with hypertension and diabetes. The strength of the present study was that we could perform a follow-up with a large-scale single cohort of sufficient sample size (approximately 15,000 subjects) over time and investigate the relationship between uric acid and new-incident metabolic syndrome.
Conclusions
We conclude that serum uric acid levels are related to new-incident metabolic syndrome independent of other factors in a Japanese general population. Further prospective studies and clinical trials are necessary to determine whether uric acid is the direct cause of metabolic syndrome and to consider the potential of uric acid as a metabolic syndrome screening agent or therapeutic target.
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